Class information for:
Level 1: ANTICONVULSANT ACTIVITY//MES TEST//EPILEPSY BRANCH

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
10290 1010 28.9 61%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
46 30816 EPILEPSY//EPILEPSIA//ANTIEPILEPTIC DRUGS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANTICONVULSANT ACTIVITY Author keyword 73 39% 15% 148
2 MES TEST Author keyword 25 70% 2% 21
3 EPILEPSY BRANCH Address 24 37% 5% 52
4 ANTICONVULSANT Author keyword 23 13% 16% 160
5 SCPTZ TEST Author keyword 17 100% 1% 8
6 VALNOCTAMIDE Author keyword 15 71% 1% 12
7 AMELTOLIDE Author keyword 15 88% 1% 7
8 MAXIMAL ELECTROSHOCK TEST Author keyword 14 59% 2% 16
9 MAXIMAL ELECTROSHOCK Author keyword 13 24% 5% 46
10 DAVID R BLOOM PHARM Address 11 19% 5% 51

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ANTICONVULSANT ACTIVITY 73 39% 15% 148 Search ANTICONVULSANT+ACTIVITY Search ANTICONVULSANT+ACTIVITY
2 MES TEST 25 70% 2% 21 Search MES+TEST Search MES+TEST
3 ANTICONVULSANT 23 13% 16% 160 Search ANTICONVULSANT Search ANTICONVULSANT
4 SCPTZ TEST 17 100% 1% 8 Search SCPTZ+TEST Search SCPTZ+TEST
5 VALNOCTAMIDE 15 71% 1% 12 Search VALNOCTAMIDE Search VALNOCTAMIDE
6 AMELTOLIDE 15 88% 1% 7 Search AMELTOLIDE Search AMELTOLIDE
7 MAXIMAL ELECTROSHOCK TEST 14 59% 2% 16 Search MAXIMAL+ELECTROSHOCK+TEST Search MAXIMAL+ELECTROSHOCK+TEST
8 MAXIMAL ELECTROSHOCK 13 24% 5% 46 Search MAXIMAL+ELECTROSHOCK Search MAXIMAL+ELECTROSHOCK
9 PYRROLIDINE 2 5 DIONES 11 100% 1% 6 Search PYRROLIDINE+2+5+DIONES Search PYRROLIDINE+2+5+DIONES
10 PHARMACOKINETIC PHARMACODYNAMIC INTERACTION 7 64% 1% 7 Search PHARMACOKINETIC+PHARMACODYNAMIC+INTERACTION Search PHARMACOKINETIC+PHARMACODYNAMIC+INTERACTION

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANTIEPILEPTIC DRUG DEVELOPMENT 131 65% 12% 123
2 ARYL SEMICARBAZONES 53 89% 2% 24
3 MAXIMAL ELECTROSHOCK SCREEN 50 86% 2% 25
4 VALNOCTAMIDE 49 94% 2% 17
5 THIOBUTYROLACTONES 34 93% 1% 13
6 N BENZYLACETAMIDE DERIVATIVES 26 87% 1% 13
7 PICROTOXIN RECEPTOR 22 68% 2% 19
8 PNU 151774E 21 90% 1% 9
9 PROPYLISOPROPYL ACETAMIDE 17 100% 1% 8
10 LY201116 15 88% 1% 7

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Chemical properties of antiepileptic drugs (AEDs) 2012 32 33 36%
Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs 2011 102 30 17%
Recent Progress in Anticonvulsant Drug Research: Strategies for Anticonvulsant Drug Development and Applications of Antiepileptic Drugs for Non-Epileptic Central Nervous System Disorders 2012 16 185 43%
New anticonvulsant agents 2005 93 102 59%
Progress report on new antiepileptic drugs: A summary of the Eleventh Eilat Conference (EILAT XI) 2013 44 77 14%
Key factors in the discovery and development of new antiepileptic drugs 2010 117 106 14%
New antiepileptic agents: structure-activity relationships 2012 4 104 56%
Semicarbazone - a versatile therapeutic pharmacophore for fragment based anticonvulsant drug design 2012 4 60 55%
THE MAXIMAL ELECTROSHOCK SEIZURE (MES) MODEL IN THE PRECLINICAL ASSESSMENT OF POTENTIAL NEW ANTIEPILEPTIC DRUGS 2009 24 33 33%
New drugs for small animals in 2013 2014 0 1 100%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 EPILEPSY BRANCH 24 37% 5.1% 52
2 DAVID R BLOOM PHARM 11 19% 5.0% 51
3 FOOD DRUG MED 9 83% 0.5% 5
4 ORGANISM FUNCT TORS CHANGBAI MT 6 30% 1.7% 17
5 MNDJOYANS FINE ORGAN CHEM 6 100% 0.4% 4
6 ANTICONVULSANT SCREENING PROGRAM 5 55% 0.6% 6
7 ISOBOLOG ANAL 4 29% 1.2% 12
8 CORP DEV ASTA MED GRP 3 100% 0.3% 3
9 PRECLIN PHARMACOL SECT 3 13% 2.3% 23
10 ANTICONVULSANT DRUG DEV PROGRAM 3 18% 1.4% 14

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000226367 LACOSAMIDE//ESLICARBAZEPINE ACETATE//PERAMPANEL
3 0.0000098871 REMACEMIDE//LOSIGAMONE//REMACEMIDE HYDROCHLORIDE
4 0.0000091650 SPECTROTYPE//CLONAL RESTRICTION//PRESSURIZED AIRLINE CABINS
5 0.0000087787 LAMOTRIGINE//FELBAMATE//OXCARBAZEPINE
6 0.0000080961 HYDANTOIN//HYDANTOINS//2 THIOHYDANTOIN
7 0.0000075235 EXPTL EPILEPSIEFOR//EXPERIMENTAL EPILEPSY MODELS//MODEL NERVOUS SYSTEM
8 0.0000074216 MOTOR SEIZURES//MED 3 PATHOPHYSIOL//POSTSYNAPTIC ELEMENT
9 0.0000072218 LEVETIRACETAM//SV2A//BRIVARACETAM
10 0.0000066940 VALPROIC ACID//VALPROATE//TRANS 2 EN VALPROATE